ALBT Q1 2026 Earnings Steep Net Loss and Stock Decline Amid Limited Disclosures THRY Q1 2026 Earnings Significant EPS Surprise Drives Positive Stock Reaction Huntington Bancshares HBANZ Q1 2026 Earnings Preferred Stock EPS Falls Short of Estimates Amid Narrowing Net Interest Margin Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress Acrivon Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline JSPR Q1 2026 Earnings Stunning EPS Beat Highlights Cost Discipline as PreRevenue Biotech Advances Pipeline